NEO100 and High-Grade Meningioma

Clinical trial NCT05023018 · RECRUITING

Trial details

NCT number: NCT05023018
Sponsor: Neonc Technologies, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Residual, Progressive or Recurrent Grade II or III Meningioma

Start date: 2022-07-01
Primary completion: 2026-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.